Somatropin(Human Growth Hormone)
- Generic Name
- Somatropin(Human Growth Hormone)
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
⑴各种原因引起的生长激素缺乏性侏儒，包括垂体病变及其下丘脑病变所致者；
⑵儿童其他原因引起的矮小症，如特纳综合征，小于胎龄儿等；
⑶成人生长激素缺乏症、儿童特发性矮小等一些国家已批准使用；
⑷烧伤、儿童慢性肾衰等；
⑸用于Prader-Will综合征；【美国FDA已批准重组人生长激素注射液用于Prader-Will综合征；中华医学会儿科学分会内分泌遗传代谢学组《中华儿科杂志》编辑委员会，《基因重组人生长激素儿科临床规范应用的建议》（2013）】
...
- Associated Conditions
- -
- Associated Therapies
- -
Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2019-06-27
- Lead Sponsor
- LG Life Sciences
- Target Recruit Count
- 34
- Registration Number
- NCT02204163
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Ajou University Hospital, Suwon, Korea, Republic of
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
- Conditions
- Interventions
- First Posted Date
- 2014-03-04
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 9
- Registration Number
- NCT02077348
- Locations
- 🇩🇰
Institute of Clinical Medicine, Aarhus, Aarhus C, Denmark
Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
- Conditions
- Interventions
- First Posted Date
- 2013-04-02
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 72
- Registration Number
- NCT01822340
- Locations
- 🇭🇺
Hanmi Pharmaceutical, Budapest, Hungary
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 18
- Registration Number
- NCT01723748
- Locations
- 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
Growth Hormone and Brain Functioning After Traumatic Brain Injury
- First Posted Date
- 2012-10-03
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Joe Springer
- Target Recruit Count
- 15
- Registration Number
- NCT01699308
- Locations
- 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
- Conditions
- Interventions
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2016-01-11
- Lead Sponsor
- Max-Planck-Institute of Psychiatry
- Target Recruit Count
- 54
- Registration Number
- NCT01397500
- Locations
- 🇩🇪
Max Planck Institute, Muenchen, Bavaria, Germany
A Study of Zomacton in Children With Growth Hormone Deficiency
- First Posted Date
- 2009-04-20
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 165
- Registration Number
- NCT00884000
- Locations
- 🇭🇺
University of Szeged, Szeged, Hungary
🇭🇺Petz Country Teaching Hospital, Gyor, Hungary
🇮🇳TOTALL Diabetes Hormone Institute, Indore, India
Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
- First Posted Date
- 2008-07-23
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Oregon Health and Science University
- Registration Number
- NCT00720616
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
- Conditions
- Interventions
- Procedure: Stable Isotope Infusion StudyProcedure: Collection of blood and tissuesDrug: HumatropeDrug: KetoconazoleDrug: Oxandrolone and propranolol combinedDrug: PlaceboDrug: Humatrope and propranolol combinedBehavioral: Exercise--Hospital supervised intensive exercise programBehavioral: Home exercise programDrug: OxandroloneDrug: Propranolol
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2019-11-29
- Target Recruit Count
- 1126
- Registration Number
- NCT00675714
- Locations
- 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
Growth Hormone Administration and the Human Immune System
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- National Institute on Aging (NIA)
- Target Recruit Count
- 66
- Registration Number
- NCT00663611
- Locations
- 🇺🇸
National Institute of Aging, Clinical Research Unit, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.